Linde plc Stock (NASDAQ: LIN) News, Forecasts and Analyst Outlook for Dec. 19, 2025

Linde plc Stock (NASDAQ: LIN) News, Forecasts and Analyst Outlook for Dec. 19, 2025

December 19, 2025 — Linde plc (NASDAQ: LIN), the world’s largest industrial gases and engineering company, is back in the spotlight on Friday as fresh institutional-filing headlines and analyst commentary collide with a familiar debate: is LIN a “premium quality compounder” temporarily marked down by macro fears, or a fully valued defensive name facing another stretch of soft industrial demand?

By early afternoon, Linde’s investor page showed shares up about 0.68% to $421.85 (1:33 p.m. ET). Linde

Linde stock today: where shares trade and what the market is watching

Friday’s trading has been relatively orderly, with LIN hovering in the low-$420s after closing near $419 on Thursday. On a technical basis, analysts and quant screens often highlight how far the stock sits from longer-term trend lines: MarketBeat reports a 50-day moving average around $423 and a 200-day moving average near $455, underscoring that the shares have not fully recaptured mid-year levels. MarketBeat

MarketBeat also lists a 52-week range of roughly $387.78 to $486.38, illustrating the stock’s wide swing in 2025 despite its reputation for stability. MarketBeat

Why that matters today: Linde’s business model is often praised for resilience—long-term contracts, critical industrial inputs, pricing discipline—but 2025 reminded investors that “defensive” doesn’t mean “immune,” especially when Europe’s industrial cycle weakens and valuation becomes the market’s favorite lever.

The Dec. 19 headlines: institutional activity and “Buy” consensus stays intact

Two of the most-circulated LIN items dated Dec. 19, 2025 are less about new operations and more about positioning:

1) Voya trims its stake (13F filing focus)

MarketBeat reports that Voya Investment Management reduced its Linde position by about 7.9%, selling 43,614 shares and ending the quarter with 506,007 shares (per the filing it references). MarketBeat

Institutional flows like this don’t automatically signal a bearish call—13F changes can reflect rebalancing, mandate shifts, or liquidity needs—but the headline lands at a time when many investors are already asking whether Linde’s “macro premium” has become too large.

2) Street consensus remains “Buy,” targets cluster around ~$500

A separate MarketBeat roundup dated today reiterates that Linde carries an analyst consensus of “Buy” and an average 12‑month target around $501. MarketBeat

If you benchmark that $501 consensus target against Friday’s ~$422 trading area, the implied upside is in the high teens—but the path to getting there is where forecasts diverge.

What management is forecasting: guidance frames the near-term ceiling

The most important baseline for any “forecast” conversation is still the company’s own guidance.

Third-quarter results: solid execution, mixed macro

Linde’s Q3 update emphasized steady operational delivery:

  • Sales around $8.6 billion (up ~3% year over year)
  • Adjusted EPS of $4.21 (up ~7% year over year)
  • Operating cash flow about $2.9 billion (up ~8%) Business Wire

Fourth-quarter and full-year 2025 EPS guidance

After Q3, Linde guided to:

  • Q4 2025 adjusted EPS:$4.10 to $4.20
  • Full-year 2025 adjusted EPS:$16.35 to $16.45 Reuters

Reuters noted the Q4 range came in below the analyst mean estimate it cited (LSEG), and management commentary pointed to ongoing pressure in Europe. Reuters

The Europe question: why it keeps showing up in every LIN debate

Europe is central to the current Linde narrative because it’s where volume softness has been most visible.

Reuters reported that EMEA volumes fell 3% in the quarter and cited management indicating the trend could persist. Reuters

That macro sensitivity also made its way into Friday’s mainstream market conversation. In a Dec. 19 item focused on Jim Cramer’s commentary, Linde was framed as an early-cycle indicator for industrial activity and reshoring signals. Insider Monkey

Cramer’s takeaway was blunt. He quoted Linde as not seeing the expected wave yet: “Where’s the reshoring? … We haven’t got the reshoring.” Insider Monkey

That doesn’t mean reshoring won’t happen—but it does capture why some investors want proof in the form of accelerating volumes before they’re willing to pay “peak multiple” again.

Analyst forecasts and price targets: bullish overall, but with notable nuance

As of Dec. 19, the analyst picture looks like this:

CICC initiation: optimistic target, supportive “fresh coverage” signal

Nasdaq’s recap of a Fintel note says CICC initiated coverage with an Outperform on Dec. 3, 2025, and it also cites a broad analyst target distribution (as compiled by Fintel at that time). Nasdaq

Even if you don’t rely on any single aggregator’s math, the key market signal is that new coverage landed bullish, reinforcing the idea that the recent sell-off created a “re-entry” narrative for some desks.

RBC: price target cut, but “Outperform” remains—macro risk is the reason

A TipRanks write-up of a TheFly note says RBC Capital lowered its price target to $490 from $540 while keeping Outperform, citing concerns tied to industrial production trends and Europe. TipRanks

The same note highlights RBC’s view that ongoing weak industrial production—especially Europe—could create an EPS drag from volume headwinds in 2026, even if the company keeps executing well. TipRanks

BMO: reiterates $501 and emphasizes multi-engine growth levers

Investing.com reports BMO reiterated Outperform and a $501 target, and summarized BMO’s thesis as confidence in Linde’s ability to sustain 10%+ EPS growth through multiple avenues—pointing to electronics, newer end-markets (including space applications), and productivity opportunities. Investing

What this mix tells investors: The “average target near $500” consensus doesn’t mean analysts agree on the journey. The bull case is still alive, but more reports are explicitly calling out that the next leg up likely requires either (1) macro stabilization, or (2) credible proof that Linde has enough internal levers to offset volume softness.

Dividend and shareholder returns: steady income, but not the main story

Linde declared a quarterly dividend of $1.50 per share, paid Dec. 17, 2025, to shareholders of record Dec. 3, 2025. Linde

At around $422 per share, that’s roughly a 1.4% annualized yield (not high, but consistent for a “quality industrial” with a long record of dividend growth). Linde

For many long-term holders, LIN’s appeal is less about headline yield and more about the combined “shareholder yield” story—dividends plus buybacks—especially when the stock trades below prior highs.

The real catalyst checklist: what could move LIN next

Looking beyond today’s headlines, here are the catalysts most likely to drive the next decisive move:

1) Evidence of improving industrial demand—especially in Europe

This is the “macro gate.” Reuters’ reporting around Europe’s volume weakness remains the key overhang narrative. Reuters

2) Execution against guidance and 2026 visibility

Because Linde has already framed Q4 EPS and reaffirmed full‑year EPS, the next earnings update becomes a test of whether guidance holds up (or improves) in a choppy demand environment. Business Wire

3) Analyst narrative shift from “valuation reset” to “re-acceleration”

This is where the target-price range matters. RBC’s note shows that even bullish analysts may be less willing to underwrite aggressive multiples until they see a clearer path through 2026 macro uncertainty. TipRanks

4) Institutional positioning: more 13F-based flow stories

With institutional ownership often cited as high, 13F-driven headlines like Voya’s trim can keep sentiment reactive in the short term—even if fundamentals don’t change that day. MarketBeat

Bull case vs. bear case: the Dec. 19 investment debate in plain English

The bull case for Linde stock

  • Pricing power + productivity can keep earnings compounding even when volumes wobble. Business Wire
  • Multiple analysts continue to cluster around $490–$510 targets, implying meaningful upside from current levels. Investing
  • Linde remains a global industrial platform tied to long-duration themes like electronics supply chains and decarbonization, even if adoption is uneven year to year. Investing

The bear case (or “why some investors hesitate”)

  • Europe volume softness has been a real data point, not just a fear. Reuters
  • If reshoring and broader industrial recovery are slower than expected, Linde may have to rely more heavily on internal levers to hit ambitious growth targets—something analysts are debating openly. TipRanks
  • The stock has historically carried a premium valuation, and valuation can compress quickly if the market decides “quality” is no longer scarce.

Bottom line on Dec. 19, 2025

As of Friday, Linde stock is trading higher near $422, with the day’s coverage dominated by analyst-consensus reaffirmations and institutional positioning headlines rather than new company operational announcements. Linde

The Street’s core forecast remains broadly constructive—targets near $500 are common—but the most credible bullish arguments increasingly hinge on whether Linde can out-execute macro weakness, especially in Europe, and whether the industrial cycle improves enough to support the next valuation expansion. Nasdaq

Stock Market Today

  • Cattle futures retreat as cash trades and boxed beef slip
    January 11, 2026, 11:24 AM EST. Live cattle futures slide at midday, down roughly $1.50 to $1.70. Cash trade is picking up, with reported strength in the North at $233 and bids around $232 in the South. The Fed Cattle Exchange auction showed no sales at $230-231. Feeder cattle futures fall $2.30 to $3.60 on Friday, while the CME Feeder Cattle Index climbs $4.92 to $368.07 on Jan. 7. APHIS reports more active New World Screwworm cases in Mexican states including Tamaulipas and San Luis Potosi. USDA Wholesale Boxed Beef prices weakened; Choice boxes fell $1.55 to $355.24, Select dipped 62 cents to $351.44, and the Chc/Sel spread sits at about $3.80. Slaughter totals: Thursday federally inspected head 117,000; week-to-date 465,000, down 10,732 versus last year.
Merck (MRK) Stock News and Forecasts for Dec. 19, 2025: Drug-Pricing Deals, FDA Fast-Track Catalysts, and Wall Street Targets
Previous Story

Merck (MRK) Stock News and Forecasts for Dec. 19, 2025: Drug-Pricing Deals, FDA Fast-Track Catalysts, and Wall Street Targets

PayPal Stock (PYPL) News, Forecasts and Analyst Calls for Dec. 19, 2025: Bank Charter Bid, Downgrades, and the 2026 Outlook
Next Story

PayPal Stock (PYPL) News, Forecasts and Analyst Calls for Dec. 19, 2025: Bank Charter Bid, Downgrades, and the 2026 Outlook

Go toTop